Olsen Keith M
University of Nebraska Medical Center, Omaha, NE, USA.
J Fam Pract. 2005 Jun;Suppl:S8-S14.
Diverse classes of medications are associated with QT interval prolongation and expose patients to the risk of potentially fatal ventricular arrhythmias. Clinicians can minimize adverse events by avoiding prescription of multiple medications associated with QT interval prolongation in high-risk patients.
多种药物类别与QT间期延长有关，使患者面临潜在致命性室性心律失常的风险。临床医生可以通过避免为高危患者开具多种与QT间期延长相关的药物来将不良事件降至最低。
